KY PHAN

Nextbio Capital Management Lp

Assets Managed

$215.37M

Holdings

Last Quarter

2026 - Q1

Filed Date

12d ago

Growth Rate

26.33%(2Q avg: 13.17%)

Sustained Growth

1 quarters

Portfolio positions

This chart displays the top 10 holdings in Nextbio Capital Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 24 positions.

Assets under management

The assets under management (AUM) of Nextbio Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 215.37M in assets, with a quarterly growth rate of 26.33% and a 2-quarter average growth rate of 13.17%. The portfolio is managed by KY PHAN, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
TERN Terns Pharmaceuticals Inc Recent Activity Increased 9.68%	14.8%	$31.871M 604,534 shares@ $52.72 avg price	Increased 9.68%
PTGX Protagonist Therapeutics Inc Recent Activity	11.24%	$24.202M 229,619 shares@ $105.41 avg price
STTK Shattuck Labs Inc Recent Activity	9.41%	$20.254M 3.15M shares@ $6.43 avg price
VOR Vor Biopharma Inc Recent Activity	8.29%	$17.839M 999,967 shares@ $17.84 avg price
CMPS Compass Pathways Plc Recent Activity Increased 168.58%	5.2%	$11.178M 2.021M shares@ $5.54 avg price	Increased 168.58%
RYTM Rhythm Pharmaceuticals Inc Recent Activity Increased 86.55%	5.1%	$10.965M 126,078 shares@ $86.98 avg price	Increased 86.55%
XENE Xenon Pharmaceuticals Inc Recent Activity Decreased -0.26%	4.95%	$10.655M 183,225 shares@ $58.16 avg price	Decreased -0.26%
PVLA Palvella Therapeutics Inc Recent Activity	4.79%	$10.307M 82,686 shares@ $124.66 avg price
ZBIO Zenas Biopharma Inc Recent Activity Increased 32.54%	3.88%	$8.343M 426,736 shares@ $19.56 avg price	Increased 32.54%
IVA Inventiva Sa - Adr Recent Activity Increased 2.68%	3.44%	$7.401M 1.333M shares@ $5.55 avg price	Increased 2.68%

1-10 of 24